STOCK TITAN

[Form 4] Standex International Corporation Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

David A. Dunbar, President/CEO/Chairman and director of Standex International (SXI), reported a sale of company stock under a pre-existing 10b5-1 trading plan. On 08/13/2025 he disposed of 16,000 shares at $200 per share. The Form 4 also corrects prior reporting: 50,962 shares were gifted to a trust for the benefit of the reporting person’s spouse on 09/12/2023 and the trust’s holdings were inadvertently omitted from subsequent reports. Following the reported sale, the filing shows the reporting person (as trustee) beneficially owned 115,576 shares (indirect). The sale was executed pursuant to trading plans dated November 22, 2024, and the Form 4 was signed on 08/14/2025.

David A. Dunbar, presidente/amministratore delegato/vicepresidente e amministratore di Standex International (SXI), ha venduto azioni della società secondo un piano di negoziazione 10b5-1 già esistente. In data 13/08/2025 sono state cedute 16.000 azioni a 200 $ l'una. Il Modulo 4 corregge inoltre dichiarazioni precedenti: il 12/09/2023 sono state donate 50.962 azioni a una trust a beneficio del coniuge della persona che effettua la comunicazione e le partecipazioni del trust erano state involontariamente omesse nei report successivi. Dopo la vendita indicata, il documento riporta che la persona che effettua la comunicazione, in qualità di trustee, deteneva beneficiariamente 115.576 azioni (indiretto). La vendita è stata eseguita conformemente ai piani di negoziazione datati 22 novembre 2024 e il Modulo 4 è stato firmato il 14/08/2025.

David A. Dunbar, presidente/CEO/presidente del consejo y director de Standex International (SXI), vendió acciones de la compañía bajo un plan de negociación 10b5-1 preexistente. El 13/08/2025 dispuso la venta de 16.000 acciones a 200 $ por acción. El Formulario 4 también corrige reportes anteriores: el 12/09/2023 se donaron 50.962 acciones a un fideicomiso en beneficio del cónyuge de la persona informante y las participaciones del fideicomiso se omitieron involuntariamente en informes posteriores. Tras la venta reportada, la presentación indica que la persona informante (como fiduciario) poseía beneficiosamente 115.576 acciones (indirectas). La venta se ejecutó conforme a planes de negociación fechados el 22 de noviembre de 2024 y el Formulario 4 fue firmado el 14/08/2025.

David A. Dunbar는 Standex International(SXI)의 회장/CEO/이사 겸 의장으로서 기존의 10b5-1 거래계획에 따라 회사 주식을 매도했습니다. 2025-08-13에 주당 200달러에 16,000주를 처분했습니다. 제출된 Form 4는 이전 보고의 정정도 포함하고 있습니다: 2023-09-12에 보고인의 배우자 이익을 위한 신탁에 50,962주가 증여되었으며 신탁 보유분이 이후 보고서에서 실수로 누락되었습니다. 보고된 매도 이후, 제출서류에 따르면 보고인(수탁인으로서)은 간접적으로 115,576주를 실질적으로 보유하고 있었습니다. 매도는 2024-11-22자 거래계획에 따라 실행되었고 Form 4는 2025-08-14에 서명되었습니다.

David A. Dunbar, président/directeur général/président du conseil et administrateur de Standex International (SXI), a cédé des actions de la société dans le cadre d'un plan de trading 10b5-1 préexistant. Le 13/08/2025, il a disposé de 16 000 actions au prix de 200 $ par action. Le Formulaire 4 corrige également des déclarations antérieures : 50 962 actions ont été données à un trust au bénéfice du conjoint de la personne déclarante le 12/09/2023 et les avoirs du trust ont été omis par inadvertance dans les rapports ultérieurs. Après la vente signalée, le dossier indique que la personne déclarante (en tant que fiduciaire) détenait bénéficiairement 115 576 actions (indirectes). La vente a été effectuée conformément aux plans de trading datés du 22 novembre 2024 et le Formulaire 4 a été signé le 14/08/2025.

David A. Dunbar, Präsident/CEO/Vorsitzender und Direktor von Standex International (SXI), veräußerte Unternehmensaktien im Rahmen eines bereits bestehenden 10b5-1-Handelsplans. Am 13.08.2025 wurden 16.000 Aktien zu je 200 $ veräußert. Das Formular 4 korrigiert zudem frühere Meldungen: Am 12.09.2023 wurden 50.962 Aktien zugunsten des Ehepartners der meldenden Person in einen Trust verschenkt, und die Bestände des Trusts wurden in nachfolgenden Berichten versehentlich weggelassen. Nach dem gemeldeten Verkauf weist die Einreichung aus, dass die meldende Person (als Treuhänder) wirtschaftlich 115.576 Aktien (indirekt) hielt. Der Verkauf erfolgte gemäß Handelsplänen vom 22. November 2024, und das Formular 4 wurde am 14.08.2025 unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider sale under a 10b5-1 plan and a corrective disclosure about prior omitted trust holdings; neutral to investors.

The sale of 16,000 shares at $200 is explicitly described as executed under an established 10b5-1 plan dated November 22, 2024, which indicates it was pre-planned rather than opportunistic trading. The corrected disclosure that 50,962 shares were gifted to a trust on 09/12/2023 clarifies beneficial ownership reporting but does not add new assets to the company balance sheet or change operational metrics. From an investor viewpoint, this filing updates insider ownership levels and improves reporting accuracy; it does not disclose material corporate events or financial results.

TL;DR: Filing shows compliance with pre-arranged trading rules and remedial reporting for an earlier omission; governance transparency improved.

The Form 4 documents a sale pursuant to a Rule 10b5-1 plan, which is a standard mechanism to provide an affirmative defense against insider trading claims when transactions are pre-authorized. The corrected inclusion of trust-held shares addresses a past reporting omission and restores accuracy to the beneficial ownership record. While the correction is important for disclosure integrity, the filing contains no indication of undisclosed related-party transactions or governance disputes.

David A. Dunbar, presidente/amministratore delegato/vicepresidente e amministratore di Standex International (SXI), ha venduto azioni della società secondo un piano di negoziazione 10b5-1 già esistente. In data 13/08/2025 sono state cedute 16.000 azioni a 200 $ l'una. Il Modulo 4 corregge inoltre dichiarazioni precedenti: il 12/09/2023 sono state donate 50.962 azioni a una trust a beneficio del coniuge della persona che effettua la comunicazione e le partecipazioni del trust erano state involontariamente omesse nei report successivi. Dopo la vendita indicata, il documento riporta che la persona che effettua la comunicazione, in qualità di trustee, deteneva beneficiariamente 115.576 azioni (indiretto). La vendita è stata eseguita conformemente ai piani di negoziazione datati 22 novembre 2024 e il Modulo 4 è stato firmato il 14/08/2025.

David A. Dunbar, presidente/CEO/presidente del consejo y director de Standex International (SXI), vendió acciones de la compañía bajo un plan de negociación 10b5-1 preexistente. El 13/08/2025 dispuso la venta de 16.000 acciones a 200 $ por acción. El Formulario 4 también corrige reportes anteriores: el 12/09/2023 se donaron 50.962 acciones a un fideicomiso en beneficio del cónyuge de la persona informante y las participaciones del fideicomiso se omitieron involuntariamente en informes posteriores. Tras la venta reportada, la presentación indica que la persona informante (como fiduciario) poseía beneficiosamente 115.576 acciones (indirectas). La venta se ejecutó conforme a planes de negociación fechados el 22 de noviembre de 2024 y el Formulario 4 fue firmado el 14/08/2025.

David A. Dunbar는 Standex International(SXI)의 회장/CEO/이사 겸 의장으로서 기존의 10b5-1 거래계획에 따라 회사 주식을 매도했습니다. 2025-08-13에 주당 200달러에 16,000주를 처분했습니다. 제출된 Form 4는 이전 보고의 정정도 포함하고 있습니다: 2023-09-12에 보고인의 배우자 이익을 위한 신탁에 50,962주가 증여되었으며 신탁 보유분이 이후 보고서에서 실수로 누락되었습니다. 보고된 매도 이후, 제출서류에 따르면 보고인(수탁인으로서)은 간접적으로 115,576주를 실질적으로 보유하고 있었습니다. 매도는 2024-11-22자 거래계획에 따라 실행되었고 Form 4는 2025-08-14에 서명되었습니다.

David A. Dunbar, président/directeur général/président du conseil et administrateur de Standex International (SXI), a cédé des actions de la société dans le cadre d'un plan de trading 10b5-1 préexistant. Le 13/08/2025, il a disposé de 16 000 actions au prix de 200 $ par action. Le Formulaire 4 corrige également des déclarations antérieures : 50 962 actions ont été données à un trust au bénéfice du conjoint de la personne déclarante le 12/09/2023 et les avoirs du trust ont été omis par inadvertance dans les rapports ultérieurs. Après la vente signalée, le dossier indique que la personne déclarante (en tant que fiduciaire) détenait bénéficiairement 115 576 actions (indirectes). La vente a été effectuée conformément aux plans de trading datés du 22 novembre 2024 et le Formulaire 4 a été signé le 14/08/2025.

David A. Dunbar, Präsident/CEO/Vorsitzender und Direktor von Standex International (SXI), veräußerte Unternehmensaktien im Rahmen eines bereits bestehenden 10b5-1-Handelsplans. Am 13.08.2025 wurden 16.000 Aktien zu je 200 $ veräußert. Das Formular 4 korrigiert zudem frühere Meldungen: Am 12.09.2023 wurden 50.962 Aktien zugunsten des Ehepartners der meldenden Person in einen Trust verschenkt, und die Bestände des Trusts wurden in nachfolgenden Berichten versehentlich weggelassen. Nach dem gemeldeten Verkauf weist die Einreichung aus, dass die meldende Person (als Treuhänder) wirtschaftlich 115.576 Aktien (indirekt) hielt. Der Verkauf erfolgte gemäß Handelsplänen vom 22. November 2024, und das Formular 4 wurde am 14.08.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Dunbar David A.

(Last) (First) (Middle)
23 KEEWAYDIN DRIVE
SUITE 300

(Street)
SALEM NH 03079

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President/CEO/Chairman
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/13/2025 S 16,000(1) D $200 115,576(2) I Trustee of Trust
Common Stock 5,398.9759 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Sale of stock pursuant to existing 10b5-1 trading plans dated November 22, 2024.
2. 50,962 shares gifted to a trust for the benefit of the reporting person's spouse and for which the reporting person is a trustee on September 12, 2023 and reported on the Form 4 filed on September 13, 2023 were inadvertently left out of the total holdings of the trust in subsequent reports.
/s/ Alan J. Glass 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Standex Intl

NYSE:SXI

SXI Rankings

SXI Latest News

SXI Latest SEC Filings

SXI Stock Data

2.51B
11.88M
1.59%
97.6%
2.42%
Specialty Industrial Machinery
Refrigeration & Service Industry Machinery
Link
United States
SALEM